
A personalised cancer vaccine that uses similar technology to the Covid jabs has produced “really hopeful” early results, researchers say.
The vaccine was given to eight head and neck cancer patients at the NHS’ Clatterbridge Cancer Centre after they had received standard treatment. None of the patients went on to relapse several months later.